Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry
- PDF / 559,653 Bytes
- 7 Pages / 595.276 x 790.866 pts Page_size
- 1 Downloads / 225 Views
ORIGINAL ARTICLE
Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry Ashutosh Kumar Arya1 · Poonam Kumari1 · Sanjay Kumar Bhadada1 · Kanhaiya Agrawal1 · Priyanka Singh1 · Soham Mukherjee1 · Ashwani Sood2 · Sudhaker D. Rao3 Received: 14 April 2020 / Accepted: 9 August 2020 © The Japanese Society Bone and Mineral Research and Springer Japan KK, part of Springer Nature 2020
Abstract Introduction Primary hyperparathyroidism (PHPT), a third common endocrine disorder, varies from asymptomatic disease, mostly seen in the West where routine biochemical screening is practiced, to the classical symptomatic disease mostly seen in the Eastern countries. We aimed to compare the demographic, clinical, biochemical measurements in patients with asymptomatic and symptomatic PHPT from the Indian PHPT registry. Material and methods Data of PHPT patients from the last 25 years (1995–2019) were analyzed for demographic, clinical presentation and biochemical measurements, and compared these characteristics between asymptomatic and symptomatic PHPT patients. Results Of the 554 patients, 54 (10%) patients had asymptomatic PHPT. There was a sharp rise in the proportion of asymptomatic PHPT patients of 3% in the first decade to 13% in the second decade of the century (p = 0.003). Patients with asymptomatic PHPT were significantly older (50 vs. 42 years; p 12 g/dL) was measured by Schiff’s method before 2005 and after that by automated blood cell counter, coulter LH 750 (Beckman Coulter, Miami FL, USA). Anemia was defined as Hb levels
Data Loading...
